Medicare AdvantageCoverageMedium impact
MA11.022a, Cryosurgical Ablation of the Prostate Gland
Independence Blue Cross·Urology·Medical Policy
Effective date
Jan 21, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.022a for Cryosurgical Ablation of the Prostate Gland has been reissued with an effective date of January 21, 2026. This is a policy update that will affect coverage and billing for prostate cryosurgical procedures under Medicare Advantage plans.
Action Required
Before January 21, 2026: Billing team must review the full policy details at the provided URL to understand any changes to coverage criteria, documentation requirements, or prior authorization for prostate cryosurgical ablation procedures. Update billing workflows and provider documentation templates as needed based on the complete policy requirements.